Tenon Medical, Inc.NASDAQ: TNON

WallachBeth Capital Announces Closing of Tenon Medical

· Issued by Tenon Medical, Inc. via PR Newswire

Summary by 6ix AI

WallachBeth Capital LLC said Tenon Medical, Inc. (NASDAQ: TNON), a medical device company focused on certain sacro-pelvic (lower spine and pelvis) disorders, closed its previously announced private placement (a sale of shares directly to an investor) with an institutional investor, with WallachBeth as exclusive placement agent.

Key details

  • Tenon agreed to sell 597,610 shares of common stock (or pre-funded warrants instead, which carry a $0.001 per share exercise price), together with a warrant to buy up to an aggregate 1,058,517 shares of common stock.
  • The combined effective offering price is $5.02 for each share with accompanying warrants, and $5.019 for each pre-funded warrant with accompanying warrants.
  • The warrant has an exercise price of $5.02 per share, will be immediately exercisable and will expire five years from the date of issuance.
  • Gross proceeds to Tenon are estimated at approximately $3.0 million before the placement agent's fees and other estimated offering expenses.
  • Tenon has agreed to provide customary registration rights for the common shares and the shares underlying the warrants and pre-funded warrants.

What’s still pending

  • The securities have not been registered under the Securities Act of 1933 or state securities laws and may not be resold in the United States except under an effective registration statement or an applicable exemption.
  • The approximately $3.0 million gross proceeds figure is an estimate.

6ix AI wrote this summary from the release below and checked it against the release.

$3M Private Placement Offering

JERSEY CITY, N.J., Aug. 31, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders closed its previously announced private placement pursuant to securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering. The combined effective offering price for each share of common stock and accompanying warrants to be issued is $5.02. The combined effective offering price for each pre-funded warrant and accompanying warrants to be issued is $5.019. The pre-funded warrants will have an exercise price of $0.001 per share of common stock and the warrant will have an exercise price of $5.02 per share, will be immediately exercisable, and will expire five years from the date of issuance.

The gross proceeds to the Company from the offering are estimated to be approximately $3.0 million before deducting the placement agent's fees and other estimated offering expenses.

WallachBeth Capital LLC acted as the exclusive placement agent in connection with the offering.

The offer and sale of the foregoing securities are being made in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and the securities have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement, the Company has agreed to provide customary registration rights for the shares of common stock and the shares of common stock underlying the warrants and pre-funded warrants.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. Any offering of the securities under the resale registration statement will only be made by means of a prospectus.

About WallachBeth Capital LLC:

WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community, connecting corporate clients with leading institutions, supporting issuers and investors in achieving their financial goals. The firm's experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions and ATM's.

Forward-Looking Statements

This press release contains "forward-looking statements," which are statements related to events, results, activities or developments that Tenon expects, believes or anticipates will or may occur in the future. Forward-looking statements often contain words such as "intends," "estimates," "anticipates," "hopes," "projects," "plans," "expects," "seek," "believes," "see," "should," "will," "would," "target," and similar expressions and the negative versions thereof. These forward-looking statements, include, but are not limited to, statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the anticipated use of proceeds therefrom. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause Tenon's actual results to be materially different than those expressed in any forward-looking statements, please review Tenon's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updated from time to time in our Form 10-Q filings and in our other public filings on file with the SEC at www.sec.gov, particularly the information contained in the section entitled "Risk Factors." We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announces-closing-of-tenon-medical-302865124.html

View original source (PR Newswire)Tenon Medical, Inc. on 6ix

Story so far

Earlier from Tenon Medical

Later from Tenon Medical

All Tenon Medical news releases